Bagsværd, Denmark, 1 October 2013 - In continuation of the company's
announcements dated 31 January 2013 and 8 August 2013 concerning planned share
repurchase programmes, and pursuant to Section 204.25 of the New York Stock
Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE:
NVO) and its wholly-owned affiliates on 30 September 2013 owned 17,893,048 of
its own B shares of DKK 1, corresponding to a total nominal value of DKK
17,893,048 or 3.3% of the total share capital.